These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2824652)

  • 1. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
    McNearney TA; Odell C; Holers VM; Spear PG; Atkinson JP
    J Exp Med; 1987 Nov; 166(5):1525-35. PubMed ID: 2824652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
    Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
    Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.
    Huemer HP; Larcher C; Dierich MP; Falke D
    Arch Virol; 1992; 127(1-4):291-303. PubMed ID: 1333754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.
    Friedman HM; Glorioso JC; Cohen GH; Hastings JC; Harris SL; Eisenberg RJ
    J Virol; 1986 Nov; 60(2):470-5. PubMed ID: 3021981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells.
    Friedman HM; Cohen GH; Eisenberg RJ; Seidel CA; Cines DB
    Nature; 1984 Jun 14-20; 309(5969):633-5. PubMed ID: 6328323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2.
    Eisenberg RJ; Ponce de Leon M; Friedman HM; Fries LF; Frank MM; Hastings JC; Cohen GH
    Microb Pathog; 1987 Dec; 3(6):423-35. PubMed ID: 2849025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.
    Hook LM; Lubinski JM; Jiang M; Pangburn MK; Friedman HM
    J Virol; 2006 Apr; 80(8):4038-46. PubMed ID: 16571820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.
    Awasthi S; Lubinski JM; Friedman HM
    Vaccine; 2009 Nov; 27(49):6845-53. PubMed ID: 19761834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
    Friedman HM; Wang L; Fishman NO; Lambris JD; Eisenberg RJ; Cohen GH; Lubinski J
    J Virol; 1996 Jul; 70(7):4253-60. PubMed ID: 8676446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells.
    Hidaka Y; Sakai Y; Toh Y; Mori R
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():915-21. PubMed ID: 1849974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.
    Harris SL; Frank I; Yee A; Cohen GH; Eisenberg RJ; Friedman HM
    J Infect Dis; 1990 Aug; 162(2):331-7. PubMed ID: 2165106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2.
    Seidel-Dugan C; Ponce de Leon M; Friedman HM; Fries LF; Frank MM; Cohen GH; Eisenberg RJ
    J Virol; 1988 Nov; 62(11):4027-36. PubMed ID: 2845122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells.
    Smiley ML; Friedman HM
    J Virol; 1985 Sep; 55(3):857-61. PubMed ID: 2991604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.
    Friedman HM; Wang L; Pangburn MK; Lambris JD; Lubinski J
    J Immunol; 2000 Oct; 165(8):4528-36. PubMed ID: 11035093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.
    Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM
    Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.